Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia
Clinical trial NCT03399786 · COMPLETED
Trial details
- NCT number
- NCT03399786
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-18
- Primary completion
- 2019-06-10
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.